`U.S. Patent No. 9,220,631
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`______________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`______________________
`
`REGENERON PHARMACEUTICALS, INC.,
`Petitioner,
`
`v.
`
`NOVARTIS PHARMA AG,
`NOVARTIS TECHNOLOGY LLC,
`NOVARTIS PHARMACEUTICALS CORPORATION,
`Patent Owner.
`______________________
`
`Case No. IPR2021-00816
`U.S. Patent No. 9,220,631
`______________________
`
`PETITIONER’S NOTICE OF SUPPLEMENTAL EVIDENCE
`
`
`
`
`
`
`
`IPR2021-00816
`U.S. Patent No. 9,220,631
`
`
`
`Petitioner Regeneron Pharmaceuticals, Inc. submits this Notice of
`
`Supplemental Evidence in Response to Patent Owners Novartis Pharma AG,
`
`Novartis Technology LLC, and Novartis Pharmaceuticals Corporation’s
`
`Objections to Petitioner’s Exhibits 1001-1090. In response to Patent Owners’
`
`objections, Petitioner submits the following Supplemental Evidence pursuant to 37
`
`C.F.R. § 42.64(b)(2):
`
`Ex.
`1091
`
`Ex.
`1092
`
`Ex.
`1093
`
`Ex.
`1094
`
`Declaration of Juergen Sigg
`
`Supplemental Declaration of Horst Koller under 37 C.F.R. § 1.68
`
`Supplemental Declaration of Szilard Kiss under 37 C.F.R. § 1.68
`
`ONDrugDelivery, Prefilled Syringe, available at
`https://ondrugdelivery.com/magazines/prefilled-syringes-the-rise-of-
`the-delivery-device-portfolio/
`
`
`
`Dated: November 23, 2021
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`
`/s/ Elizabeth Stotland Weiswasser
`Elizabeth S. Weiswasser (Reg. No. 73,760)
`Anish R. Desai (Reg. No. 73,760)
`Natalie Kennedy (Reg. No. 68,511)
`Andrew Gesior (Reg. No. 76,588)
`Weil, Gotshal & Manges LLP
`767 Fifth Avenue
`New York, NY 10153
`T: 212-310-8000
`1
`
`
`
`IPR2021-00816
`U.S. Patent No. 9,220,631
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`F: 212-310-8007
`E: Regeneron.IPR.Service@weil.com
`
`Brian E. Ferguson (Reg. No. 36,801)
`Christopher Pepe (Reg. No. 73,851)
`Weil, Gotshal & Manges LLP
`2001 M Street NW, Suite 600
`Washington, DC 20036
`T: 202-682-7000
`F: 202-857-0940
`E: Regeneron.IPR.Service@weil.com
`
`2
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`IPR2021-00816
`U.S. Patent No. 9,220,631
`
`CERTIFICATE OF SERVICE
`I hereby certify that on November 23, 2021, copies of the foregoing
`
`PETITIONER’S NOTICE OF SUPPLEMENTARY EVIDENCE was served
`
`via electronic mail, upon the following:
`
`Elizabeth J. Holland
`Linnea Cipriano
`Goodwin Procter LLP
`620 Eighth Avenue
`New York, NY 10018
`EHolland@goodwinlaw.com
`LCipriano@goodwinlaw.com
`
`William G. James
`Goodwin Procter LLP
`1900 N Street, N.W.
`Washington, D.C. 20036
`WJames@goodwinlaw.com
`
`Joshua Weinger
`Goodwin Procter LLP
`100 Northern Avenue
`Boston, MA 02210
`JWeinger@goodwinlaw.com
`
`DG-NovartisPFS@goodwinlaw.com
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`3
`
`/Lauren McDuffie/
`Lauren McDuffie
`IP Paralegal
`Weil, Gotshal & Manges LLP
`2001 M Street N.W., Suite 600
`Washington, D.C. 20036
`202-682-7000
`lauren.mcduffie@weil.com
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`